30 results
Key Characteristics of Old and New Potassium-Binding Agents

- Dr. Edgar V. Lerma https://twitter.com/edgarvlermamd

#Potassium #Binding #KBinders #Kayexelate
Potassium-Binding Agents ... KBinders #Kayexelate #Comparison ... #Table #Pharmacology ... #HyperKalemia #Nephrology ... #Agents
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Papillomavirus Infections ... infection ... 3 years • Co-testing ... Treatment #management #opportunistic ... #pharmacology
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
CNS Opportunistic ... Most CNS opportunistic ... of serum CrAg testing ... comparable to CSF testing ... InfectiousDiseases #Neurology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Bacterial Enteric Infections ... in HIV-AIDS Preventing ... Treatment #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pocket Cards - Pharmacologic ... • Neuropathic agents ... Opioid #Conversion #Table ... #agents #internship ... #guide #comparison
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Preventing and Treating ... in HIV-AIDS Preventing ... Treating Acute Infection ... Treatment #management #opportunistic ... #pharmacology
Table 22 provides the characteristics of various phosphate-binding agents.
#Pharmacology #Nephrology #Phosphate #Phosphorus #Binders #Comparison #Table #Disadvantages
Table 22 provides ... phosphate-binding agents ... #Pharmacology #Nephrology ... Phosphorus #Binders #Comparison ... #Table #Disadvantages
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Leishmaniasis in HIV-AIDS ... Treating Visceral ... Treatment #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
Recommendations for Treating ... in HIV-AIDS Treating ... 800 mg) PO (or IV ... Treatment #management #opportunistic ... #pharmacology
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
) Infections in ... HIV-AIDS Treating ... Infections: • ... Treatment #management #opportunistic ... #pharmacology